Correlation Between Neurobo Pharmaceuticals and BWV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and BWV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and BWV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and BWV, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and BWV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of BWV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and BWV.

Diversification Opportunities for Neurobo Pharmaceuticals and BWV

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Neurobo and BWV is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and BWV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BWV and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with BWV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BWV has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and BWV go up and down completely randomly.

Pair Corralation between Neurobo Pharmaceuticals and BWV

Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to under-perform the BWV. But the stock apears to be less risky and, when comparing its historical volatility, Neurobo Pharmaceuticals is 1.21 times less risky than BWV. The stock trades about -0.01 of its potential returns per unit of risk. The BWV is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  129.00  in BWV on October 21, 2024 and sell it today you would lose (17.00) from holding BWV or give up 13.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy25.05%
ValuesDaily Returns

Neurobo Pharmaceuticals  vs.  BWV

 Performance 
       Timeline  
Neurobo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neurobo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
BWV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BWV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BWV is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Neurobo Pharmaceuticals and BWV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurobo Pharmaceuticals and BWV

The main advantage of trading using opposite Neurobo Pharmaceuticals and BWV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, BWV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BWV will offset losses from the drop in BWV's long position.
The idea behind Neurobo Pharmaceuticals and BWV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation